Published 2 days ago • loading... • Updated 16 hours ago

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro

Eli Lilly filed lawsuits on Tuesday against Strive Pharmacy and Empower Clinic Services for selling unapproved tirzepatide products.
These lawsuits arose after the FDA clarified its stance and began enforcing regulations against compounded GLP-1 drugs.
Lilly alleges the pharmacies falsely advertise personalized versions of its drugs, Mounjaro and Zepbound, while mass-producing them.
Lilly claims the pharmacies' products are not clinically tested and falsely suggest they are safer or more effective; Zepbound costs $1,000 monthly.
These lawsuits test Lilly's ability to combat compounding pharmacies and could set a precedent for Novo Nordisk and other manufacturers.

Insights by Ground AI

Does this summary seem wrong?

12 Articles

All

Left

Center

Right

STAT

Center

Pharmalittle: We're reading about a 'miracle' HIV drug program, Lilly going after compounders, and more

A U.S. court sided with the the Department of Health and Human Services in a fight over a Vertex Pharmaceuticals fertility program

2 days ago·Boston, United States

Read Full Article

CNBC

Reposted by

Stockxpo - A professional network of traders, investors and analysts

Center

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.

2 days ago·United States

Read Full Article

Quartz

Center

Eli Lilly is coming after makers of copycat versions of Zepbound

Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and Zepbound.Read more...

2 days ago·United States

Read Full Article

gponline.com

GPs to prescribe tirzepatide from June in phased primary care rollout

GPs will be able to start prescribing the weight loss injection tirzepatide (Mounjaro) to a defined group of patients from June, according to new NHS England guidance.

16 hours ago

Read Full Article

Los Angeles Weekly Times

Eli Lilly sues Strive and Empower over compounded tirzepatide - Los Angeles Weekly Times

The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the Food and Drug Administration’s ban on the practice and luring people away from Lilly’s medicines. In lawsuits filed Tuesday in Delaware and New Jersey, Lilly alleges the two companies — Strive Pharmacy and Emp…

23 hours ago

Read Full Article